Fármaco |
NCT01504867 |
Ácido acetilsalicílico |
LIPS-A: Lung Injury Prevention Study with Aspirin
|
Ognjen Gajic|Beth Israel Deaconess Medical Center/Montefiore Medical Center/Vanderbilt University/Mayo Clinic |
400 |
Fármaco |
NCT01659307 |
Ácido acetilsalicílico |
The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury
|
Belfast Health and Social Care Trust/The Intensive Care Society United Kingdom/Northern Ireland Clinical Trials Unit/Queen's University, Belfast |
33 |
Fármaco |
NCT00112164 |
Proteína C ativada |
Activated Protein C to Treat Acute Lung Injuries
|
University of California, San Francisco/National Heart, Lung, and Blood Institute |
90 |
Fármaco |
NCT02106975 |
Ácido ascórbico |
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury
|
Virginia Commonwealth University/National Heart, Lung, and Blood Institute |
170 |
Fármaco |
NCT01434121 |
Ácido ascórbico |
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis
|
Virginia Commonwealth University |
24 |
Fármaco |
NCT01050699 |
Dexmedetomidina |
Sleep Intervention During Acute Lung Injury
|
University of Arizona/National Heart, Lung, and Blood Institute |
90 |
Fármaco |
NCT00351533 |
Óleo de peixe |
A Phase II Randomized Trial of Fish Oil in Patients with Acute Lung Injury (ALI)
|
University of Washington/National Heart, Lung, and Blood Institute/American Thoracic Society/Acute Respiratory Distress Syndrome Foundation/American Society for Parenteral and Enteral Nutrition |
90 |
Fármaco |
NCT01335932 |
Ganciclovir/Valganciclovir |
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
|
Fred Hutchinson Cancer Research Center/National Heart, Lung, and Blood Institute/Genentech, Inc. |
160 |
Fármaco |
NCT01713309 |
Proteína ligante de heparina |
Heparin Binding Protein in Patients with Acute Respiratory Failure Treated with GCSF (Filgrastim)
|
Helsinki University Central Hospital/The Swedish Research Council |
59 |
Fármaco |
NCT02425579 |
Monóxido de carbono inalado |
Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
|
Weill Medical College of Cornell University/Brigham and Women's Hospital/Massachusetts General Hospital/Duke University |
48 |
Fármaco |
NCT00605696 |
Insulina |
Evaluating the Effectiveness of Early Insulin Therapy in People at Risk for Developing Acute Lung Injury/Acute Respiratory Distress Syndrome
|
National Heart, Lung, and Blood Institute |
90 |
Fármaco |
NCT01096771 |
Lipídeos endovenosos |
The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)
|
Methodist Research Institute, Indianapolis |
14 |
Fármaco |
NCT01938079 |
Cetamina |
Pharmacokinetic Alterations During ECMO
|
Columbia University |
20 |
Fármaco |
NCT00159510 |
Azul de metileno e óxido nítrico |
Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome
|
Northern State Medical University|Helse Nord |
28 |
Fármaco |
NCT00655928 |
N-acetilcisteína |
Modulation of Lung Injury Complicating Lung Resection
|
Imperial College London/Royal College of Physicians/Royal Brompton & Harefield NHS Foundation Trust |
47 |
Fármaco |
NCT01573715 |
Agentes bloqueadores neuromusculares |
Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
|
Assistance Publique Hopitaux de Marseille |
40 |
Fármaco |
NCT00299650 |
Agentes bloqueadores neuromusculares |
Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients
|
Assistance Publique Hopitaux De Marseille/GlaxoSmithKline |
340 |
Fármaco |
NCT02509078 |
Agentes bloqueadores neuromusculares |
Reevaluation Of Systemic Early Neuromuscular Blockade
|
Massachusetts General Hospital/National Heart, Lung, and Blood Institute |
1.408 |
Fármaco |
NCT00036062 |
Inibidor de elastase neutrofílica |
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
|
Eli Lilly and Company |
600 |
Fármaco |
NCT00219375 |
Inibidor de elastase neutrofílica |
Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated with Systemic Inflammatory Response Syndrome (SIRS) in Japan
|
Ono Pharmaceutical Co. Ltd |
649 |
Fármaco |
NCT01391481 |
Perfluorocarbono inalatório |
Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
|
Chinese PLA General Hospital/The Second Artillery General Hospital/The 306 Hospital of People's Liberation Army/First Hospitals Affiliated to the China PLA General Hospital/General Hospital of Chinese Armed Police Forces/Beijing Shijitan Hospital/Air Force |
200 |
Fármaco |
NCT02370095 |
Análogo de prostaciclina |
Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
|
--- |
NR |
Fármaco |
NCT01274481 |
Análogo de prostaciclina |
Iloprost Effects on Gas Exchange and Pulmonary Mechanics
|
University of Oklahoma/Actelion |
20 |
Fármaco |
NCT00455767 |
Inibidor proteico da elastase neutrofílica humana |
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
|
Debiopharm International SA |
84 |
Fármaco |
NCT01597635 |
Enzima conversora de angiotensina tipo 2 recombinante humana |
The Safety, Tolerability, PK and PD of GSK2586881 in Patients with Acute Lung Injury
|
GlaxoSmithKline |
43 |
Fármaco |
NCT00996840 |
Inibidor seletivo de p38 alfa (MAPK) |
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
|
GlaxoSmithKline |
90 |
Fármaco |
NCT02166853 |
Sevofluorano |
Effects of SEvoflurane on Gas Exchange and Inflammation in Patients with ARDS (SEGA Study)
|
University Hospital, Clermont-Ferrand |
50 |
Fármaco |
NCT01619280 |
Nitroprussiato de sódio |
Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury
|
Mount Sinai Hospital, Canada |
30 |
Fármaco |
NCT00979121 |
Estatinas |
Statins for Acutely Injured Lungs From Sepsis
|
National Heart, Lung, and Blood Institute |
745 |
Fármaco |
NCT00562835 |
Esteroides |
Steroids in Patients with Early ARDS
|
Catholic University of the Sacred Heart |
400 |
Fármaco |
NCT00773058 |
Esteroides |
Effect of Treatment with Stress-Doses Glucocorticoid in Patients with Acute Respiratory Distress Syndrome (ARDS)
|
Southeast University, China|Nanjing Medical University |
100 |
Fármaco |
NCT01284452 |
Esteroides |
Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients with Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
|
Mahidol University |
197 |
Fármaco |
NCT00290602 |
Esteroides |
Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
|
National Cancer Center, Korea |
40 |
Fármaco |
NCT01783821 |
Esteroides |
LIPS-B: Lung Injury Prevention Study With Budesonide and Beta
|
Mayo Clinic/Stanford University/Beth Israel Deaconess Medical Center/University of Arizona/National Center for Research Resources |
61 |
Fármaco |
NCT02819453 |
Esteroides |
Corticosteroid Mediates Acute Respiratory Distress Syndrome
|
Shanghai Pulmonary Hospital, Shanghai, China |
20 |
Fármaco |
NCT00127985 |
Esteroides |
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
|
Hospital Universitario Principe de Asturias/Pfizer |
240 |
Fármaco |
NCT00742482 |
Surfactante |
Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy
|
LEO Pharma |
418 |
Fármaco |
NCT01462279 |
Tiamina |
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
Beth Israel Deaconess Medical Center|American Medical Association |
20 |
Fármaco |
NCT02895191 |
Inibidor de tripsina urinária |
The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
|
Techpool Bio-Pharma Co., Ltd./The First Affiliated Hospital of Guangzhou Medical University |
60 |
Fármaco |
NCT00004494 |
Peptídeo intestinal vasoativo |
Phase I Study of Vasoactive Intestinal Peptide in Patients with Acute Respiratory Distress Syndrome and Sepsis
|
Stony Brook University/State University of New York/FDA Office of Orphan Products Development |
18 |
Fármaco |
NCT02468531 |
Anestesia com xenônio |
The Clinic Trial on Protection of Xenon Anaesthesia against Perioperative Acute Lung Injury for Standford a Acute Aortic Dissection
|
Beijing Anzhen Hospital |
80 |